Rick Bartels, MBA

Senior Consultant Managed Markets

Mr. Bartels is experienced in all aspects of pharmaceutical commercialization. Mr. Bartels expertise includes but is not limited to new product launches, strategy and tactical plan development, market research, patient access and payer strategy development. He possess primary care, biologic, orphan drug, rare disease and medical device marketing expertise across multiple therapeutic areas.

Mr. Bartels enjoyed a successful 21 year career at AstraZeneca where he held numerous sales and marketing leadership roles with an ever expanding scope of responsibility including Marketing Director – Respiratory Brands, Market Research Manager, New Products Planning Manager and District Sales Manager.

Following AstraZeneca Mr. Bartels was Marketing Director at CSL Behring, responsibility for immunology and critical care biologic products. Mr. Bartels led the highly successful launch of Privigen, surpassing launch forecast. Additionally, he spearheaded the development of an innovative patient advocacy strategy resulting in 25% increase in patient retention.

As his diverse career progressed, Mr. Bartels became Global Head of Sales and Marketing for RMS Medical products, a manufacturer of medical devices and supplies. During his tenure, RMS enjoyed a 26.4% increase in revenue and net income improved by 65.1% driven by strong sales.

Currently, Mr. Bartels is D2 Senior Consultant Managed Markets where he takes the lead role supporting companies in designing launch and reimbursement strategies for pharmaceutical, biotech and medical device products. He also specializes in qualitative market research methods and data analysis.

Mr. Bartels holds a Bachelor of Marketing degree from the SUNY Polytechnic Institute and a MBA from Russel Sage College. In addition, Mr. Bartels serves as an Adjunct Assistant Professor, Healthcare Business MBA program at the University of Sciences in Philadelphia.